Technical Analysis for ACST - Acasti Pharma, Inc.

Grade Last Price % Change Price Change
grade C 1.48 -1.99% -0.03
ACST closed down 1.99 percent on Wednesday, December 13, 2017, on 25 percent of normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.
Track This Stock
Watchlist Portfolio
Trend Table & Recent Alerts
ADX Long-Term Intermediate-Term Short-Term
Strong Up Up Down
See historical ACST trend table...

Date Alert Name Type % Chg
Dec 13 1,2,3 Pullback Bullish Bullish Swing Setup 0.00%
Dec 13 Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 0.00%
Dec 13 Wide Bands Range Expansion 0.00%
Dec 13 Oversold Stochastic Weakness 0.00%
Dec 12 Stochastic Buy Signal Bullish -1.99%
Dec 12 Narrow Range Bar Range Contraction -1.99%
Dec 12 Wide Bands Range Expansion -1.99%
Dec 12 Oversold Stochastic Weakness -1.99%
Dec 11 Wide Bands Range Expansion -7.50%
Dec 11 Up 3 Days in a Row Strength -7.50%

Older signals for ACST ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio.
Basic chart:

Profile
Acasti Pharma Inc., a biopharmaceutical company, focuses on the research, development, and commercialization of new therapies for abnormalities in blood lipids, and the treatment and prevention of cardiovascular disorders. The company offers Onemia, a medical food that is used in the dietary management of illnesses associated with omega-3 phospholipids deficiency related to cardiometabolic disorders. Its product development pipeline includes CaPre, a drug product candidate that is in Phase II clinical trial for the prevention and treatment of cardiometabolic disorders, including hypertriglyceridemia. The company was incorporated in 2002 and is headquartered in Laval, Canada. Acasti Pharma Inc. is a subsidiary of Neptune Technologies & Bioressources Inc.
Is ACST a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 4 bullish, 0 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 3.36
52 Week Low 1.11
Average Volume 613,052
200-Day Moving Average 1.3384
50-Day Moving Average 1.4632
20-Day Moving Average 1.698
10-Day Moving Average 1.581
Average True Range 0.1822
ADX 30.34
+DI 33.59
-DI 21.88
Chandelier Exit (Long, 3 ATRs ) 2.8134
Chandelier Exit (Short, 3 ATRs ) 1.7766
Upper Bollinger Band 2.4803
Lower Bollinger Band 0.9157
Percent B (%b) 0.36
BandWidth 92.143698
MACD Line 0.0129
MACD Signal Line 0.0551
MACD Histogram -0.0422
Fundamentals Value
Market Cap 21.78 Million
Num Shares 14.7 Million
EPS -0.77
Price-to-Earnings (P/E) Ratio -1.92
Price-to-Sales 0.00
Price-to-Book 1.22
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 1.66
Resistance 3 (R3) 1.68 1.63 1.63
Resistance 2 (R2) 1.63 1.59 1.63 1.62
Resistance 1 (R1) 1.56 1.56 1.60 1.54 1.61
Pivot Point 1.51 1.51 1.53 1.51 1.51
Support 1 (S1) 1.44 1.47 1.48 1.42 1.35
Support 2 (S2) 1.39 1.44 1.39 1.34
Support 3 (S3) 1.32 1.39 1.33
Support 4 (S4) 1.30